82 related articles for article (PubMed ID: 21187133)
1. Systems biology approach to study permeability of paracetamol and its solid dispersion.
Khan S; Elshaer A; Rahman AS; Hanson P; Perrie Y; Mohammed AR
Int J Pharm; 2011 Sep; 417(1-2):272-9. PubMed ID: 21187133
[TBL] [Abstract][Full Text] [Related]
2. Genomic evaluation during permeability of indomethacin and its solid dispersion.
Khan S; Elshaer A; Rahman AS; Hanson P; Perrie Y; Mohammed AR
J Drug Target; 2011 Sep; 19(8):615-23. PubMed ID: 21080758
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis.
Qi S; Gryczke A; Belton P; Craig DQ
Int J Pharm; 2008 Apr; 354(1-2):158-67. PubMed ID: 18242020
[TBL] [Abstract][Full Text] [Related]
4. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
6. Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions.
Khan S; Batchelor H; Hanson P; Saleem IY; Perrie Y; Mohammed AR
Drug Dev Ind Pharm; 2013 May; 39(5):704-15. PubMed ID: 22639985
[TBL] [Abstract][Full Text] [Related]
7. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
Campbell K; Craig DQ; McNally T
Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
[TBL] [Abstract][Full Text] [Related]
10. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
Rahman Z; Zidan AS; Khan MA
Int J Pharm; 2010 Nov; 400(1-2):49-58. PubMed ID: 20801200
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
13. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
14. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
Wang X; Michoel A; Van den Mooter G
Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing.
Yang M; Wang P; Huang CY; Ku MS; Liu H; Gogos C
Int J Pharm; 2010 Aug; 395(1-2):53-61. PubMed ID: 20435110
[TBL] [Abstract][Full Text] [Related]
16. Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions.
Mirza S; Heinämäki J; Miroshnyk I; Rantanen J; Christiansen L; Karjalainen M; Yliruusi J
J Pharm Sci; 2006 Aug; 95(8):1723-32. PubMed ID: 16795009
[TBL] [Abstract][Full Text] [Related]
17. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the microstructure of semicrystalline solid dispersions.
Zhu Q; Taylor LS; Harris MT
Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
[TBL] [Abstract][Full Text] [Related]
19. Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process.
Park JH; Chi SC; Lee WS; Lee WM; Koo YB; Yong CS; Choi HG; Woo JS
Arch Pharm Res; 2009 Jan; 32(1):139-48. PubMed ID: 19183887
[TBL] [Abstract][Full Text] [Related]
20. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
